SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001753926-21-000333
Filing Date
2021-08-12
Accepted
2021-08-11 21:55:32
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-1 g082291_f1.htm F-1 2298293
2 EXHIBIT 10.11 g082291_ex10-11.htm EX-10.11 260423
3 EXHIBIT 10.13 g082291_ex10-13.htm EX-10.13 233654
4 EXHIBIT 23.1 g082291_ex23-1.htm EX-23.1 5147
5 GRAPHIC g082291_img1.jpg GRAPHIC 21498
6 GRAPHIC g082291_img2.jpg GRAPHIC 34015
7 GRAPHIC g082291_img3.jpg GRAPHIC 97049
8 GRAPHIC g082291_img4.jpg GRAPHIC 13533
  Complete submission text file 0001753926-21-000333.txt   3022069
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-258741 | Film No.: 211165392
SIC: 2834 Pharmaceutical Preparations